17.92MMarket Cap-1675.00P/E (TTM)
3.4200High3.2200Low13.32KVolume3.3600Open3.3000Pre Close44.65KTurnover0.26%Turnover RatioLossP/E (Static)5.35MShares11.790052wk High0.85P/B17.40MFloat Cap2.910152wk Low--Dividend TTM5.19MShs Float1461.9999Historical High--Div YieldTTM6.06%Amplitude2.3100Historical Low3.3510Avg Price1Lot Size
Lipocine Stock Forum
FDA Lifts Critical Cardiovascular Warning for Testosterone Treatments: Major Win for Lipocine
📊⚡️📊
nfa
nfa
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
$KULR Technology (KULR.US)$ PR 12/17: Signs Service Agreement to Launch KULR ONE Space Battery. COH $13.4M good for 9 months✅
$Wearable Devices (WLDS.US)$ PR 12/17:...
FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
Tuesday, 17th December at 8:00 am
SALT LAKE CITY, Dec. 17, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track Designation t...
📊⚡️📊
No comment yet